Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 26, 15:32
1720.00 -17.50 (-1.01%)
Volume
AVERAGE VOLUME
5-Day
148,278
10-Day
118,792
30-Day
77,533
140,613
  • Prev. Close

    1737.50

  • Open Price

    1727.20

  • Bid Price (Qty.)

    1720.00 (1)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 26, 15:31
1719.50 -17.50 (-1.01%)
Volume
AVERAGE VOLUME
5-Day
2,209,447
10-Day
1,861,201
30-Day
1,974,517
2,507,229
  • Prev. Close

    1737.00

  • Open Price

    1737.00

  • Bid Price (Qty.)

    1713.90 (194)

  • Offer Price (Qty.)

    1714.00 (16)

Financials

Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
Per Share Ratios  
Basic EPS (Rs.) -6.10 -13.70 5.00 16.40 13.40  
Diluted EPS (Rs.) -6.10 -13.70 5.00 16.40 13.40  
Cash EPS (Rs.) -3.93 -13.16 5.82 17.12 13.98  
Book Value [ExclRevalReserve]/Share (Rs.) 109.78 35.77 75.21 76.07 64.51  
Book Value [InclRevalReserve]/Share (Rs.) 109.78 35.77 75.21 76.07 64.51  
Dividend / Share(Rs.) 3.00 1.50 5.00 4.25 3.50  
Revenue from Operations/Share (Rs.) 38.71 13.66 23.49 38.78 30.01  
PBDIT/Share (Rs.) -1.68 0.94 7.24 20.30 14.67  
PBIT/Share (Rs.) -4.87 0.45 6.41 19.57 14.05  
PBT/Share (Rs.) -7.53 -13.52 6.40 16.67 14.04  
Net Profit/Share (Rs.) -7.12 -13.66 4.99 16.39 13.36  
Profitability Ratios  
PBDIT Margin (%) -4.32 6.88 30.80 52.34 48.87  
PBIT Margin (%) -12.56 3.28 27.27 50.45 46.80  
PBT Margin (%) -19.44 -99.02 27.26 42.97 46.78  
Net Profit Margin (%) -18.38 -99.99 21.23 42.27 44.52  
Return on Networth / Equity (%) -6.48 -38.18 6.63 21.54 20.71  
Return on Capital Employed (%) -3.81 0.91 8.19 24.97 21.32  
Return on Assets (%) -3.93 -20.44 5.58 18.58 18.19  
Total Debt/Equity (X) 0.24 0.33 0.01 0.01 0.01  
Asset Turnover Ratio (%) 0.31 0.25 0.26 0.48 0.44  
Liquidity Ratios  
Current Ratio (X) 0.49 1.40 3.37 3.90 5.97  
Quick Ratio (X) 0.30 1.15 2.61 3.27 5.18  
Inventory Turnover Ratio (X) 1.46 1.00 0.94 1.51 1.21  
Dividend Payout Ratio (NP) (%) -48.97 -10.98 100.24 25.92 26.19  
Dividend Payout Ratio (CP) (%) -88.75 -11.39 85.95 24.82 25.03  
Earnings Retention Ratio (%) 148.97 110.98 -0.24 74.08 73.81  
Cash Earnings Retention Ratio (%) 188.75 111.39 14.05 75.18 74.97  
Valuation Ratios  
Enterprise Value (Cr.) 216,735.09 121,019.78 84,360.34 57,690.01 44,552.43  
EV/Net Operating Revenue (X) 27.03 42.78 34.69 14.37 14.34  
EV/EBITDA (X) -624.52 621.16 112.59 27.45 29.33  
MarketCap/Net Operating Revenue (X) 26.41 41.98 34.85 14.69 14.72  
Retention Ratios (%) 148.97 110.98 -0.24 74.07 73.80  
Price/BV (X) 9.31 16.03 10.88 7.49 6.85  
Price/Net Operating Revenue 26.41 41.98 34.85 14.69 14.72  
Earnings Yield -0.01 -0.02 0.01 0.03 0.03  
Source : Dion Global Solutions Limited

Results of Sun Pharma

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347